World

The landscape of global trade is marred by heightened tensions, particularly as a result of the United States’ increasingly aggressive tariffs aimed at China, among other nations. Recently, a staggering 34% tariff was announced by the Trump administration, pushing the burden of U.S.-China trade relations to a breaking point. Beijing has rapidly shifted into a

In a dramatic turn of events, the unveiling of President Donald Trump’s sweeping tariffs has sent shockwaves through the U.S. stock market, creating a climate of uncertainty that many believed was behind us. With a baseline tariff rate of at least 10%, and in some instances even steeper increases, the financial community is grappling with

In a bold move reminiscent of historical bullies, the U.S. government, under President Donald Trump’s directive, has initiated a barrage of tariffs that is shaking the foundations of international trade. The aggressive imposition of tariffs—34% on China, 20% on the European Union, 46% on Vietnam, and 32% on Taiwan—signals a new era where diplomatic negotiations

The recent announcement of a 25% tariff on imported cars not manufactured in the United States has set off alarm bells throughout the automotive industry. Predominantly affecting Asian automakers, this policy change instigated a dramatic sell-off in the stock market, sending shares of leading manufacturers plunging. Notably, Toyota’s stock experienced a 9.4% decrease in the

In a climate fraught with challenges and uncertainties, Huawei has proven remarkably resilient, demonstrating a significant rebound in its financial performance in 2024. The company reported a staggering revenue of 862.1 billion Chinese yuan (approximately $118.2 billion), marking an impressive 22.4% increase from the previous year. This achievement not only highlights Huawei’s capacity for astonishing

In a world where economic alliances shape geopolitical landscapes, the recent dialogue between South Korea, China, and Japan signals a much-needed revival in regional cooperation. After a five-year hiatus, these three Asian titans convened on Sunday with the intention of reinvigorating trade amidst external pressures, particularly from U.S. tariffs introduced by former President Donald Trump.

In a shocking escalation, the Trump administration is extending its controversial stance against diversity, equity, and inclusion (DEI) programs beyond U.S. borders, targeting European companies with stringent demands. Reports indicate that American government officials have sent stern letters to firms across France and the EU, asserting that adherence to a recently enacted executive order banning

Novo Nordisk, once a shining star in the pharmaceutical universe, is currently grappling with a troubling reality as it faces backlash for the unimpressive results of their obesity treatment, CagriSema. In an industry that thrives on groundbreaking advancements, the expectation was set high for this next-generation drug. As a combination of cagrilintide and semaglutide—two compelling

On Thursday, investors faced another round of turbulence as President Trump’s latest tariff proposal sent ripples through the stock market. The Dow Jones Industrial Average plunged by 216 points, equating to a 0.5% decline, while both the S&P 500 and Nasdaq Composite experienced downturns of 0.3% and 0.4%, respectively. It’s becoming alarmingly evident that the

In an era where economic news is often spun with a silver lining, the recent rise in Asia-Pacific markets can lure many into a false sense of security. Gains in the Australian S&P/ASX 200 and Japan’s Nikkei 225 reflect a superficial resilience in the face of tumultuous trade policies. While Wall Street celebrated minor victories